Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Dual-degenerate TCRs target multiple KRAS hotspot and HLA-A3 family combinations.

Research square·2026

Same author

Cuproptosis-immunity crosstalk informs strategy to overcome immunotherapy resistance.

Cell·2026

Same author

Deciphering small sequence differences in T cell receptor-antigen pairing.

Nature communications·2026

Same author

Clinical outcomes and predictors of response to PD-(L)1 blockade in patients with NSCLC without actionable genomic alterations who never used tobacco.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity.

JCO precision oncology·2026

Same author

A two-tier framework for responsible research on human embryo models.

Cell·2026

Search research articles

Related Experiment Video

Updated: Jun 2, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Clinical trials for stem cell therapies.

Alan Trounson¹, Rahul G Thakar, Geoff Lomax

¹California Institute for Regenerative Medicine, 210 King Street, San Francisco, CA 9107, USA. atrounson@cirm.ca.gov

|May 17, 2011

Summary

Stem cell research is advancing, exploring bone marrow and cord blood stem cells beyond blood disorders. Early trials show mixed results, prompting research into neural and pluripotent stem cells for broader therapeutic applications.

More Related Videos

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Related Experiment Videos

Last Updated: Jun 2, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

Area of Science:

Regenerative Medicine
Cell Biology
Clinical Therapeutics

Background:

Bone marrow and cord blood stem cells are established treatments for blood and immune disorders.
Mesenchymal stem cells are being investigated for applications beyond their native cell lineage.
Neural stem cells and pluripotent stem cells represent emerging areas in stem cell therapy.

Purpose of the Study:

To review the expanding directions of clinical trials involving various stem cell types.
To assess the current progress and challenges in utilizing stem cells for novel therapeutic applications.
To highlight the initiation of clinical trials using pluripotent stem cell-derived therapies.

Main Methods:

Review of recent clinical trial data and research trends in stem cell therapy.
Analysis of studies focusing on mesenchymal, neural, and pluripotent stem cells.
Evaluation of outcomes from trials exploring cell replacement and extracellular factor effects.

Main Results:

Early clinical trials with mesenchymal stem cells show mixed results, with minor or temporary improvements.
Extracellular factors are considered a potential mechanism for observed therapeutic effects.
Clinical trials utilizing neural stem cells and pluripotent stem cell-derived therapies are underway.

Conclusions:

Stem cell research is diversifying, moving beyond traditional applications.
Further research is needed to understand the mechanisms and optimize outcomes for novel stem cell therapies.
The development of therapies from pluripotent stem cells marks a significant advancement in the field.